马鞭草苷通过抑制PI3K-AKT通路减轻肠上皮炎症改善小鼠克罗恩病样结肠炎

  • 打印
  • 收藏
收藏成功


打开文本图片集

Abstract:ObjectiveToinvestigatethetherapeuticefectofverbenalin(VE)onCrohn'sdisease(CD)-likecolitisandthe underlying molecular mechanism.Methods FiftyC57BL/6 mice wererandomlydivided into control group,TNBS group,and low-,medium-,and high-dose VE treatment groups( n=10) .Mouse modelsof CD-likecolitiswereestablished inall but the control group by enema with 25mg/L TNBS dissolved in ethanol, and the mice in VE treatment groupsreceived daily intraperitoneal injectionsofVEat 5,10,or 20mg/kg for7days. Cultured colon organoids derived from mouse cryptswere exposed to 100μg/mL lipopolysaccharide (LPS) for 24h andtreatedwith5,0,or 20μmol/L VE.The therapeutic effects of VE inthemousemodelsereevaluatedbyssessngangesinseaseactivitydex,stopathologicalsoress index.Inbotholonicmucosaoftemousemodelsandthecolonorganoids,thelevelsofinflammatorycytokines,xpsio of tightjunctionproteins,andchangesinPI3K-AKTpathwayproteins wereanalyzed,andtheregulatorymechanismof VE wasverifiedusingthePI3K-AKTagonist740Y-P.ResultsInTNBS-treatedmice,VEtreatmentsignificantlyreducedDAI histopathological scores,andspleen index,and mitigatedweightloss,colonshorteningandbacterial translocation.VE obviously lowered the expression of pro-inflammatorycytokines in colonicmucosa of the miceandthe colon organoids, upregulated ZO-1andclaudin-1expreions,andreducedbacterialtranslocation.VEsignificantlydownregulatedp-3Kand p-AKT proteinexpresions,whichwasreversedbytreatment with740Y-P.Conclusion VEinhibitsintestinalinflammation and protects intestinal barier function in mice with CD-like colitis by modulating the PI3K-AKT signaling pathway. Keywords:Crohn'sdisease;inflammatoryboweldisease;intestinalbarrier;PI3K-AKT;verbenalin

克罗恩病(CD)是一种慢性炎症性肠道疾病,发病率逐年上升,其临床表现多为腹痛、腹泻及肠梗阻等,严重影响患者生活质量[1-3]。(剩余14796字)

monitor